BALANCE SHEETS - USD ($)	Mar. 31, 2017	Sep. 30, 2016
CURRENT ASSETS:
Cash and cash equivalents	$ 1,529,802	$ 2,917,996
Receivables	4,252	394,515
Prepaid expenses	720,466	981,677
Deposits - current portion	150,000	154,995
Inventory used for R&D and manufacturing	678,664	1,008,642
Total current assets	3,083,184	5,457,825
PROPERTY AND EQUIPMENT, net	17,087,085	17,350,836
PATENT COSTS, net	239,214	256,547
DEPOSITS	1,670,917	1,820,917
TOTAL ASSETS	22,080,400	24,886,125
CURRENT LIABILITIES:
Accounts payable	7,074,898	3,091,512
Accrued expenses	509,841	378,672
Due to employees	607,289	538,278
Derivative instruments, current portion	208,493	0
Other current liabilities	7,792	3,310
Total current liabilities	8,408,313	4,011,772
Derivative instruments - net of current portion	3,228,252	8,394,934
Lease liability	13,110,357	13,011,023
Deferred revenue	125,000	125,000
Other liabilities	40,478	22,609
Total liabilities	24,912,400	25,565,338
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' DEFICIT
Preferred stock, $.01 par value-200,000 shares authorized; -0- shares issued and outstanding	0	0
Common stock, $.01 par value - 600,000,000 shares authorized; 8,655,685and 6,235,035 shares issued and outstanding at March 31, 2017 and September 30, 2016, respectively	86,557	62,350
Additional paid-in capital	287,377,903	284,649,559
Accumulated deficit	(290,296,460)	(285,391,122)
Total stockholders' deficit	(2,832,000)	(679,213)
TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT	$ 22,080,400	$ 24,886,125